Looking to invest in biotech stocks? Learn what they are, explore top options, and find out how to get started in this fast-growing, exciting industry.

A premium-priced private placement gives Agenus $85 million upfront as it shifts resources to one colon-cancer trial.

Biotech remains one of the market's more out-of-favor sectors despite improving industry fundamentals. Here are three stocks trading near multiyear lows.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

NurPhoto/Getty Images VC funding for European biotech startups is on track for a record year, though the gap with the US ...

The selected startups include Fermbox Bio, Revelations Biotech, 4baseCare, Sea6 Energy and Telluris Biotech, the sources said ...

Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that ...

Michael Yee, UBS biotech analyst, joins 'The Exchange' to discuss Yee's thoughts on biotech stocks, what's driving the ...

VERAXA Biotech (NASDAQ: VRXA) announced a collaboration with AI-driven bioinformatics company Ardigen S.A. to support ...

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

CNBC’s Jim Cramer pushed viewers away from the usual semiconductor and hyperscaler chatter. Instead, he highlighted a group ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.